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Abstract
Alcohol and other drug (AOD) use is increasingly recognised as having a direct and indirect effect on the transmission of
human immunodeﬁciency virus (HIV). However, there is evidence to suggest that drug- and sex-related HIV risk-reduction
interventions targeted at drug users within drug treatment centres or via community outreach efforts can lead to positive
health outcomes. This study aimed to test whether a community-level intervention aimed at AOD users has an impact on
risky AOD use and sexual risk behaviour. In 2007, in collaboration with a local non-governmental organisation (NGO) in
Durban, an initiative was begun to implement a number of harm reduction strategies for injection and non-injection drug
users. The NGO recruited peer outreach workers who received intensive initial training, which was followed by six-
monthly monitoring and evaluation of their performance. Participants had to be 16 years of age or older, and self-
reported alcohol and/or drug users. Peer outreach workers completed a face-to-face baseline questionnaire with
participants which recorded risk behaviours and a risk-reduction plan was developed with participants which consisted of
reducing injection (if applicable) and non-injection drug use and sex-related risks. Other components of the intervention
included distribution of condoms, risk-reduction counselling, expanded access to HIV Testing Services, HIV/sexually
transmitted infection care and treatment, and referrals to substance abuse treatment and social services. At follow-up, the
baseline questionnaire was completed again and participants were also asked the frequency of reducing identiﬁed risk
behaviours. Baseline information was collected from 138 drug users recruited into the study through community-based
outreach, and who were subsequently followed up between 2010 and 2012. No injection drug users were reached. The
data presented here are for ﬁrst contact (baseline) and the ﬁnal follow-up contact with the participants. There were no
decreases in drug use practices such as use of cannabis, heroin, cocaine and Ecstasy after the intervention with drug
users; however, there was a signiﬁcant reduction in alcohol use following the intervention. While there was a substantial
increase in the proportion of participants using drugs daily as opposed to more often, the reduction in the frequency of
drug use was not statistically signiﬁcant. Following the intervention, drug users had signiﬁcantly fewer sexual partners, but
there were no signiﬁcant differences following the intervention with regard to frequency of sex or use of condoms.
Substance use in general and during sex was, however, decreased. While the ﬁndings were mixed, the study shows that it
is possible to provide HIV risk-reduction services to a population of substance users who are less likely to receive
services through community outreach, and provide risk-reduction information, condoms and condom demonstration and
other services. More intensive interventions might be needed to have a substantial impact on substance use and substance
use-related HIV risk behaviours.
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Re´sume´
La consommation d’alcool et des autres drogues (AAD) est de plus en plus reconnue comme ayant un effet direct et indirect sur la
transmission du virus d’immunode´ﬁcience humaine (VIH). Toutefois, il existe des preuves pour sugge´rer que les interventions de
re´duction du risque du VIH lie´ aux drogues et a` l’activite´ sexuelle, ciblant les utilisateurs de drogues dans les centres de traitement de
la toxicomanie, ou par des efforts de sensibilisation communautaires, peuvent avoir des effets be´ne´ﬁques pour la sante´. La pre´sente
e´tude avait pour but de tester si une intervention au niveau communautaire visant les consommateurs d’AAD, a un impact sur
consommation d’AAD ainsi que les comportements sexuels a risque. En 2007, en collaboration avec une organisation non-
gouvernementale (ONG) locale a` Durban, il fuˆt entrepris de mettre en œuvre un certain nombre de strate´gies de re´duction du
risque au be´ne´ﬁce des utilisateurs de drogues injectables et non-injectables (UDIs/UDNIs). L’ONG a recrute´ des pairs agents
communautaires qui ont rec¸u une formation intensive initiale, suivie d’un monitorage et de l’e´valuation semestrielle de leur
performance. Les participants e´taient aˆge´s d’au moins 16 ans, et auto-de´clare´s consommateurs d’alcool et/ou utilisateur de
drogues. Les pairs agents communautaires ont rempli un questionnaire de base au cours des rencontres en face-a`-face avec les
participants, portant sur les comportements a` risque. Le plan de re´duction du risque e´tait ensuite e´labore´ avec les participants et
consistait en la re´duction de l’usage des drogues injectables (le cas e´che´ant) et non-injectables, et des comportements sexuels a
risque. Les autres composantes de l’intervention incluaient la distribution des pre´servatifs, les conseils sur la re´duction du risque,
l’expansion de l’acce`s aux services de de´pistage du VIH, au traitement et a` la prise en charge du VIH et des affections
sexuellement transmises, et les re´fe´rences aux services sociaux et de traitement de la toxicomanie. Lors du suivi le questionnaire
de base fuˆt rempli encore, et les participants enqueˆte´s sur la fre´quence de re´duction des comportements a` risque identiﬁe´s. Les
informations de base ont e´te´ recueillies chez 138 utilisateurs de drogues recrute´s dans l’e´tude graˆce a` la sensibilisation
communautaire. Ils ont ensuite e´te´ suivis entre 2010 et 2012. Aucun utilisateur de drogues injectables n’a e´te´ recrute´. Les
donne´es du premier contact (donne´es de base) et celles du contact ﬁnal lors du suivi des participants, sont pre´sente´es ici. Il n’y
a pas eu de re´duction des pratiques d’utilisation des drogues telles que le cannabis, l’he´roı¨ne, la cocaı¨ne et l’Ectasie suite a`
l’intervention chez les utilisateurs de drogues; toutefois, il y avait une re´duction signiﬁcative de la consommation d’alcool suite a
l’intervention. Bien qu’il y ait eu d’augmentation substantielle de la proportion de participants utilisant la drogue
quotidiennement par opposition a` plus souvent, la re´duction de la fre´quence d’utilisation de la drogue n’e´tait pas
statistiquement signiﬁcative. Suite a` l’intervention, les utilisateurs de drogue avaient signiﬁcativement moins de partenaires
sexuels, mais il n’y avait de diffe´rences signiﬁcatives en ce qui concerne la fre´quence des rapports sexuels ou d’utilisation du
pre´servatif, suite a` l’intervention. L’utilisation de la drogue en ge´ne´ral et lors de l’acte sexuel avait cependant diminue´. Bien que
les re´sultats fussent meˆle´s, cette e´tude montre qu’il est possible de procurer de services de re´duction du risque du VIH a` une
population d’utilisateurs de la drogue, qui est moins susceptible de recevoir de tels services par la sensibilisation communautaire;
et de de´livrer les conseils sur la re´duction du risque, les pre´servatifs et de´monstrations sur l’usage des pre´servatifs, et bien
d’autres services. Des interventions plus intensives sont peut-eˆtre ne´cessaires ou avoir un impact substantiel sur l’usage des
drogues les comportements a` risque pour le VIH lie´s a` l’usage des drogues.
Mots cle´s: comportements a` risque pour le VIH, consommation de l’alcool et autres drogues, intervention, sensibilisation
communautaire
Background
Approximately 7 million people in South Africa are infected with
the human immunodeﬁciency virus (HIV), accounting for 19.2%
of adults aged 15–49 (The Joint United Nations Programme on
HIV/AIDS [UNAIDS], 2017). In addition to the HIV epidemic
gripping South Africa, the country has also experienced changes
in drug consumption following its transition to democracy in
1994 and a rapid increase in the transshipment of a wide
variety of drugs through South Africa and re-entry into the inter-
national drug-trafﬁcking market. From the late 1990s and 2000s,
this has led to an increased consumption of a broad range of drugs
previously unavailable (Parry & Pithey, 2006; UNODC, 2005).
KwaZulu-Natal is the province with the highest estimated HIV
prevalence at 16.9% (Shisana et al., 2014), as well as known
high levels of alcohol and other drug (AOD) use (Dada et al.,
2017).
AOD use is increasingly recognised as playing a direct and indir-
ect role in the transmission of HIV. This occurs directly, through
the sharing of injection drug use paraphernalia and also
indirectly, as AOD use can reduce inhibitions and impair judge-
ment thus impacting on risky sexual encounters such as having
multiple sexual partners and increased length of sexual encoun-
ters (Rosengard, Anderson, & Stein, 2004; Semple, Patterson, &
Grant, 2004). Additionally, various studies have demonstrated
inconsistent condom use among drug-using populations
(Abdool, Sulliman, & Dhanoo, 2006; Dewing, Pluddemann,
Myers, & Parry, 2006; McCurdy, Williams, Kilonzo, Ross, &
Leshabari, 2005). Locally, studies have also demonstrated the
impact of drug use on risky sexual behaviour where drug use
facilitates high-risk sexual behaviour such as having multiple
partners and inconsistent condom use (Parry, Carney, Petersen,
Dewing, & Needle, 2008, 2009). Few studies have investigated
HIV prevalence among drug users in South Africa. A report
indicated the HIV prevalence among drug users in this
country to be between 5.4% and 35% depending on the sub-
population studied (e.g. injection drug users (IDUs) and non-
injection drug users (NIDUs)) and other factors (Scheibe,
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Brown, Duby, & Bekker, 2011). They also concluded that further
research is needed to better quantify the extent to which drug
use impacts HIV status.
There is evidence to suggest that drug- and sex-related HIV risk-
reduction interventions for drug users can lead to positive health
outcomes (Copenhaver, Lee, & Margolin, 2007). Behavioural
interventions targeting HIV risk behaviours among HIV positive
and negative people have been recommended as an effective
measure to minimise HIV transmission attributable to AOD
use (Samet, Walley, & Bridden, 2007). In particular, Parry
et al. (2009), following a rapid assessment of injecting and
non-injecting drug users in three cities in South Africa, rec-
ommended that HIV and drug prevention and treatment
efforts should be made more accessible and be better integrated
with other services, and that community-based outreach efforts
among those populations is needed to address HIV and drug
risk. Community-based outreach programmes to reduce the
spread of HIV/AIDS among drug users have been shown to be
feasible in other African countries such as Kenya (Deveau,
Levine, & Beckerleg, 2006), and with female commercial sex
workers (CSWs) in Durban and with men-who-have sex with
men (MSM) in Pretoria, South Africa (Carney, Petersen Wil-
liams, & Parry, 2016; Petersen Williams, Carney, & Parry,
2016). The latter projects involved creating partnerships
between public health researchers and NGOs, and the employ-
ment by the NGOs of community-based peer outreach
workers. In Brazil, the utility of involving community health
workers (CHWs) in primary care and serving as a liaison
between community members and medical providers and
researchers has been researched. It has been found that colla-
borative experiences between different role players can facilitate
the timely sharing of research ﬁndings with practitioners
working on the ground and a more integrated approach can
improve the quality of care provided to persons in need
(Pinto, Wall, Yu, Penido, & Schmidt, 2012). The research con-
ducted in Brazil has also shown how CHWs through empathetic
communication and perseverance are able to promote patient
health behaviours (Pinto, da Silva, & Soriano, 2012) and how
certain providers are more willing to adopt evidence-based prac-
tices and respond positively to scientiﬁc input than others (Pinto,
Yu, Spector, Gorroochurn, & McCarty, 2010).
Despite the recognition of the role of AOD use on HIV trans-
mission, there is limited availability of HIV risk-reduction ser-
vices within South African substance abuse facilities (Myers,
2010). Given the association between HIV risk behaviour and
drug use, Myers (2010) argues that coupled with South Africa’s
high HIV prevalence rate, a strong case can be made for upscaling
efforts to provide integrated HIV risk-reduction and substance
abuse treatment services. Furthermore, although the drafting of
South Africa’s Third National Drug Master Plan gave prominence
to the need to address drug abuse as part of broader HIV preven-
tion efforts (Department of Social Development, 2013), interven-
tions targeting this population group to address drug use and
sexual risk behaviour in South Africa are scarce. The aim of this
study was to test whether a community-level intervention
aimed at AOD users has an impact on risky AOD use and
sexual risk behaviour.
Methods
In 2007, in collaboration with a local non-governmental organis-
ation (NGO) (the South African National Council on Alcoholism
and Drug Dependence – SANCA) in Durban, an initiative was
begun to implement a number of harm reduction strategies for
IDUs and NIDUs. The NGO was selected based on its expertise
and extensive experience working with the speciﬁc target popu-
lation. Between 2010 and 2012, a formal evaluation was under-
taken of the extent of behaviour change that had been effected
by the intervention among drug users who were accessed
through outreach during that time and who were followed up at
least once.
Participants and data collection
The intervention was conducted in various neighbourhoods in the
eThekweni Metropolitan Municipality (Durban), South Africa, an
area that comprises over three million inhabitants in both urban
and rural communities. The estimated household size is 3.4 and
over 30% of the population is unemployed (Statistics South
Africa, 2013). A number of locations were targeted including
streets in residential and industrial areas, and hotspots where
drug users are known to frequent, such as shelters and commu-
nity-based organisations. In addition, it became apparent after
discussions with organisations in their network that it was impor-
tant to consider reaching the target population through other
institutions such as further education training colleges and spiri-
tual establishments.
To be included in the study, participants had to be 16 years of age
or older, and self-reported alcohol and/or drug users. At the time
of project conception, Department of Health guidelines which
now prohibit the inclusion of 16- and 17-year-olds without par-
ental consent had not been established and participants of this
age were able to sign informed consent as per ethics approval.
The quantity of alcohol or drugs used by the participants was
not used as an exclusion criterion, as long as they self-reported
substance use in the past 90 days. Participants who were eligible
for inclusion and willing to participate signed an informed
consent form. Peer outreach workers completed a face-to-face
baseline questionnaire with participants, which recorded risk
behaviours and a risk-reduction plan was developed with each
drug user which consisted of IDU/NIDU-related risks, sex-
related risks and HIV testing. Risk behaviours recorded included
the use of different kinds of drugs (alcohol, cannabis, heroin,
Ecstasy, cocaine, methamphetamine, inhalants, methcathinone
and over-the-counter or prescription drugs) in the past 90 days,
frequency of use of drugs, number of sex partners (male and
female), the number of times they had engaged in different
kinds of sexual behaviours (vaginal, anal and oral sex) in the
past 90 days, condom use during different kinds of sex acts
(vaginal sex, receptive anal sex, insertive anal sex and oral sex)
and whether they had traded sex for money during the past 90
days. Intervals between follow-up appointments were not speci-
ﬁed, but in some instances, outreach workers made appointments
for follow-up at a time that suited the participants, and in other
instances, follow-up appointments occurred spontaneously
when outreach workers met up with participants at various
events or social gatherings. At follow-up, the same questionnaire
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that had been administered at baseline was completed again. Par-
ticipants were also asked how often they had engaged in each of a
number of listed risk-reduction behaviours and whether they had
been tested for HIV, had asked their partner to test for HIV or
encouraged a friend to be tested. Behaviour change was thus
self-reported and not observed. Ethics approval for conducting
the study was granted by the Health Research Committee of the
University of Stellenbosch (N08/07/184).
Intervention
SANCA staff received training over ﬁve days on an intervention
that was based on a local adaptation of the World Health Organ-
ization’s Training guide for HIV prevention outreach to injecting
drug users (Burrows, 2004). A local adaptation lessened the
focus on injection drug use-related behaviours and increased
the focus on substance-related sexual HIV-risk behaviour. In
addition, the adapted manual emphasised drugs commonly
used in South Africa. Furthermore, training was provided to
SANCA staff throughout the project (via six-monthly or more fre-
quent visits) by staff from the South African Medical Research
Council (SAMRC). Between 2010 and 2012, SANCA recruited
20 peer outreach workers on a volunteer basis and they were
paid a modest stipend. Project coordinators were appointed
within the organisation to ensure the smooth running of the
project and acted as the liaison between the SANCA and the
SAMRC project manager. The intervention included the follow-
ing: administering a short baseline questionnaire to ﬁnd out
about individual risk behaviours (such as types of substances
used, frequency of use and sexual activities). They then developed
a risk-reduction plan together with the client, which consisted of
non-injection drug use (NIDU) related risks, sex-related risks and
plans for HIV counselling and testing (HCT). The intervention
session which was then offered to the clients included education
about HIV, condom demonstration and the provision of referrals
as needed.
At the follow-up appointment, both the questionnaire and risk-
reduction plan were discussed again with the client to assess be-
haviour change and revise risk-reduction plans.
Intervention practices were monitored on a monthly basis and
evaluated bi-annually. This was done through observations by
the project coordinators who rated outreach workers’ perform-
ance in terms of provision of basic HIV information, discussion
of a risk-reduction plan, referral to HCT, condom demonstrations
and provision of relevant referrals. On a six-monthly basis, a
sample of drug-using participants was also provided with a ques-
tionnaire to assess what interventions they had been offered and
about their experience of the intervention process, i.e. did they
ﬁnd it a positive experience? The outcomes of these evaluations
by project coordinators and drug-using participants were used
to inform the training of the outreach workers and HCT counsel-
lors. The HCT outcomes were not disclosed to the SAMRC staff
but were used by SANCA to make referrals to care and treatment
where necessary.
Data analysis
Demographic information was collected at baseline, and
descriptive statistics were provided on these variables. Data
on substance use and sexual risk behaviour were collected at
baseline and at each follow-up appointment. We assessed the
normality of the data collected using the Shapiro–Wilks test
of normality, and the results indicated that the data were
non-normally distributed (p , 0.001). Therefore, we conducted
bivariate analyses with continuous data (number of sex part-
ners, number of times engaged in sex, number of times had
unprotected sex, number of times traded sex, number of
times had sex while under the inﬂuence of substances). The
Wilcoxon Signed Rank Test was used to determine whether
the difference from baseline to follow-up was statistically sig-
niﬁcant. For categorical data, we assessed the differences in pro-
portions (types of substances used, types of substances used
during sex) and used the chi-square tests of association. All
statistics were analysed using 95% conﬁdence intervals. IBM
Statistical Package for the Social Sciences (SPSS) version 21
was used for data analyses.
Results
Sample characteristics
In total, baseline information was collected from 138 drug users
recruited into the study through community-based outreach,
whose substance abuse and HIV risk proﬁle was assessed and
who then received an intervention and were subsequently fol-
lowed up between 2010 and 2012. Of these, 44.2% had one
repeat contact, 34.8% had two repeat contacts, 10.9% had three
repeat contacts, 1.4% had four repeat contacts, 3.6% had ﬁve
repeat contacts and 0.7% had between six and eight repeat con-
tacts with outreach workers. The data presented here are for
ﬁrst contact (baseline) and the ﬁnal follow-up contact with the
particular client. The median age was 30 years (IQR: 17–54)
and drug users had a median of 11 years of formal education
(IQR: 0–24). Almost half of the drug users reached were
employed (49.6%) and had a partner (69.6%) (Table 1). All par-
ticipants were NIDUs, as no IDUs were identiﬁed through the
outreach and recruitment process.
Substance use
Table 2 outlines the proportion of drug users using each sub-
stance at baseline (time1) and last follow up (time2) and the
difference between these two times. Substances which were
used by less than 5% of the sample were excluded from the
table. There were only statistically signiﬁcant reductions in
the proportion of drug users using alcohol (p ¼ 0.03) from
time1 to time2. No signiﬁcant differences were observed over
time for cannabis, cocaine, heroin and Ecstasy use. There was
also no signiﬁcant change in the frequency of substance use
(p ¼ 0.08). At time1, 41.3% reported daily use of substances
and 39.1% reported daily use at time2, while more drug users
were using substances once a week or less often and fewer
using two to six days a week (Table 2). The use of more
than one substance (polydrug use) was recorded at time1 and
time2. In total, 45.7% of drug users did not report any
changes in the number of different substances used, 23.2%
increased the number of different substances they used and
31.1% decreased the total number of different substances used
over the follow-up period; however, this difference was not stat-
istically signiﬁcant (p ¼ 0.172).
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Sexual risk behaviour and substance use
Following the intervention, drug users had signiﬁcantly fewer sex
partners (z ¼ 22.84; p ¼ 0.005); however, there were no
signiﬁcant differences with regard to frequency of sex or use of
condoms (Table 3). Table 4 shows that there were signiﬁcant
reductions in the frequency of times that participants had sex
while using substances (p ¼ 0.05), as well as the proportion of
drug users using cannabis (p ¼ 0.04) during sex from time1 to
time2, while no signiﬁcant differences were observed for
alcohol, cocaine, heroin, Ecstasy and inhalant use during sex
from time1 to time2. In total, 39.1% of the drug users did not
report any changes in the number of different substances used
during sex, 21.7% increased the number of different substances
that they used during sex and 39.1% decreased the total number
of different substances used during sex.
Discussion
Following this brief behavioural intervention, there were not
any decreases in drug use practices such as use of cannabis,
heroin, cocaine and Ecstasy; however, there was a signiﬁcant
reduction in alcohol use over time. Previous studies indicate
that brief behavioural interventions such as this one have
been successful in reducing the amount of alcohol used by sub-
stance-using participants even outside of treatment settings
(McCambridge & Kypri, 2011; Moyer, Finney, Swearingen, &
Vergun, 2002). In addition, the reduction of alcohol use
among NIDUs is important because alcohol use has been
associated indirectly with HIV through risky sex behaviours
and alcohol is one of the substances targeted in behavioural
interventions for drug users (Lan, Scott-Shedon, Carey,
Johnson, & Carey, 2014; Samet et al., 2007).
Table 1. Participant demographic
characteristics (N 5 138) community-level risk-
reduction intervention, KwaZulu-Natal
Province, South Africa, 2010–2012.
Demographic variables n %
Gender
Male 125 90.6
Female 13 9.4
Occupation
Unemployed 68 49.6
Employed 46 33.6
Student/pupil 4 2.9
Other 19 13.9
Marital status
Single 30 22.2
Partner 94 69.6
Married – opposite sex 7 5.2
Married – same sex 1 0.7
Divorced/separated 1 0.7
Other 2 1.5
Table 2. Prevalence of substance use at Time1 and Time2 (N 5 138 participants).
Substance N (Time1) N (Time2) z p
Alcohol 124 111 2.22 (0.02; 0.18) 0.026∗
Cannabis 73 65 0.96 (20.06; 0.18) 0.335
Cocaine 9 3 1.75 (20.004; 0.09) 0.080
Heroin 13 14 20.20 (20.08; 0.06) 0.845
Ecstasy 7 4 0.93 (20.02; 0.07) 0.351
Frequency of use % Time1 % Time2
∗∗ 0.078
Once a week or less 23.2 32.6
2–6 days a week 35.5 26.1
Daily 41.3 39.1
Change in drug and alcohol N % 0.172
No change 63 45.7
Increase in AODs by
1 29 21.0
2 3 2.2
3 0 0.0
Decrease in AODs by
1 33 23.9
2 8 5.8
3 2 1.4
∗Signiﬁcance level p , 0.05.
∗∗3 (2.2%) missing.
Original Article
Journal of Social Aspects of HIV/AIDS VOL. 14 NO. 1 2017114
While there was a substantial increase in the proportion of par-
ticipants using drugs daily as opposed to more often following
the intervention, the reduction in the frequency of drug use was
not statistically signiﬁcant (p ¼ 0.08). Even if use per se for
illicit drugs did not decrease, a reduction in the number of
times substances are used in a given period of time is likely
to reduce harms at both an individual and at a population
level (Wechsberg et al., 2008). Following the provision of the
intervention, risky sexual practices in general were not
reduced. Among other ﬁndings, there was no signiﬁcant
change (increase) in condom use during sex following the inter-
vention. This could possibly be due to the type of sexual
partner that the participants had. For example, a recent sys-
tematic review that addressed condom use in sub-Saharan
Africa and Asia found that there is not much evidence on
the intervention impact on condom use in casual relationships
and in primary partnerships, unless one partner was HIV posi-
tive, engaged in high-risk behaviour or were trying to avoid
Table 3. Sexual risk behaviour reported at time1 and time2 (in the past 90 days).
Sexual risk Median (range) Time1 Median (range) Time2 z p
Number of sex partners 2 (0–36) 1 (0–12) 22.839 0.005∗
Number of male partners 0 (0–10) 0 (0–48) 21.929 0.054
Number of female partners 1 (0–36) 1 (0–8) 23.627 0.000∗
Times had vaginal sex 15 (0–90) 15 (0–90) 20.152 0.879
Times had receptive anal sex 0 (0–10) 0 (0–1) 21.857 0.063
Times had insertive anal sex 0 (0–40) 0 (0–24) 21.025 0.305
Times had oral sex 0 (0–41) 0 (0–30) 21.389 0.165
Times used condoms for vaginal sex 2 (0–90) 0 (0–30) 20.522 0.602
Times used condoms for receptive anal sex 0 (0–0) 0 (0–0) 0.000 1.000
Times used condoms for insertive anal sex 0 (0–0) 0 (0–0) 0.000 1.000
Times used condoms for oral sex 0 (0–16) 0 (0–1) 21.761 0.078
Times traded sex for money 0 (0–80) 0 (0–80) 22.105 0.035∗
∗Signiﬁcance level p , 0.05.
Table 4. Sexual risk and substance use reported at time1 and time2 (during past 90 days).
Substance N (Time1) N (Time2) z p
Alcohol during sex 81 67 1.68 (20.02; 0.22) 0.092
Cannabis during sex 80 63 2.04 (0.01; 0.24) 0.041∗
Cocaine during sex 6 2 1.45 (20.01; 0.07) 0.148
Heroin during sex 8 13 21.13 (20.10; 0.03) 0.259
Ecstasy during sex 5 4 0.33 (20.04; 0.05) 0.743
Inhalants during sex 28 25 0.29 (20.06; 0.08) 0.773
Frequency of use during sex Median (IQR) Time1 Median (IQR) Time2 z p
Times had sex while using drugs and alcohol 5 (0–80) 5 (0–90) 21.99 0.046∗
Change in drug and alcohol use while having sex N %
No change 54 39.1
Increase in AODs by
1 26 18.8
2 4 2.9
3 0 0.0
Decrease in AODs by
1 40 29.0
2 13 9.4
3 1 0.7
∗Signiﬁcance level p , 0.05.
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becoming pregnant (Foss, Hossain, Vickerman, & Watts, 2007).
The only signiﬁcant change was that there was a decrease in the
number of sexual partners reported at the follow-up period,
which again is likely to lead to a reduction in harms at both
an individual and population level (Kalichman et al., 2008;
Mah & Halperin, 2010).
Substance use in general and during sex was decreased following
the delivery of the intervention. Although this does not directly
speak to the amount of risk reduced, having sex while intoxicated
has been found in previous South African studies to be associated
with impaired judgement, and reduced condom use and other
risky sex behaviours (Kalichman, Simbayi, & Cain, 2010; Parry
& Pithey, 2006; Wechsberg et al., 2012). However, the only sub-
stance that was speciﬁcally mentioned as being used less during
sex following the intervention was cannabis. Although cannabis
has not traditionally been linked to sexual risk behaviour, there
is some evidence that it is speciﬁcally related to high-risk behav-
iour (Carney, PetersenWilliams, Pluddeman, & Parry, 2015; Hen-
dershot, Magnan, & Bryan, 2010).
The study is one of the ﬁrst conducted in South Africa with
NIDUs that shows that it is possible to provide HIV risk-
reduction services to this population of substance users who are
less likely to receive services through community outreach, and
provide risk-reduction information, condoms, condom demon-
stration and other services as suggested by the World Health
Organization guidelines (Burrows, 2004). This is similar to the
ﬁndings of Deveau et al. (2006) who implemented such a commu-
nity-based HIV prevention intervention for injection drug use in
other African countries. While such interventions have on
occasion been provided to a broad range of drug users attending
drug treatment centres (Copenhaver et al., 2007; Grella, Ether-
idge, Joshi, & Anglin, 2000; Lally et al., 2005), community out-
reach to reduce HIV risk has generally not been a feature of
interventions aimed at drug users who are not CSWs, MSM or
IDUs. While not speciﬁcally studied, in line with the ﬁndings of
Pinto, da Silva, and Soriano (2012) and Pinto, Wall, et al.
(2012), it is highly likely that our choice of peer outreach
workers of similar age and race to most of the drug-using study
participants as well as their empathetic communication and per-
severance also played a role in facilitating some of the behaviour
changes that were observed.
The results of this study also need to be interpreted carefully as
there were a number of limitations. First, because of the explora-
tory nature of the research and the fact that we were seeking to get
the NGO to implement new outreach activities and interventions
which would be evaluated in terms of their outcomes rather than a
more controlled experiment, the study did not include a control
group. It is thus not possible to determine if the changes we
observed as a result of the risk-reduction counselling and other
interventions would have occurred spontaneously. The sample
size was also limited due to the intensity of the outreach and
follow-up activities and thus it is possible that real changes over
time were not detected. Furthermore, drug users themselves
self-reported their substance use, and no biological tests were con-
ducted. While peer outreach workers established relationships
with drug users which may have improved the validity of self-
reporting, the conﬁrmation of substance use by urinalysis may
have added to the legitimacy of the study. The time between base-
line and follow-up assessments with the outreach workers, and
therefore between intervention and assessments, also varied
between participants meaning that for some there was more of
a recency effect of the intervention than for others. In addition,
participants were only recruited from one municipality in
KwaZulu-Natal. It is therefore uncertain if the ﬁndings of this
study are generalisable to substance users in South Africa
overall, especially as there are cultural nuances in alcohol and
drug culture in different parts of the country. Furthermore,
although the study aimed to target both IDUs and NIDUs,
IDUs were not reached in this study. IDUs have a number of
additional risks for HIV associated with their injecting use, such
as sharing needles and re-using syringes (Reid, 2009; Samet
et al., 2007), as found in previous South African studies conducted
by the current authors (Parry et al., 2009).
Future studies could target IDUs speciﬁcally, to assess if commu-
nity-based interventions could be implemented in South Africa as
they have been in other African countries (Deveau et al., 2006). In
addition, it would be advantageous for future research to have an
increased sample size to increase the statistical power of the ana-
lyses and also to include a control group (possibly a group of drug
users on a wait list) so as to also reduce the possibility of any
changes being observed as a result of other factors that had not
been accounted for, such as reduced availability of drugs in the
area. Having some or all of the participants provide biological
specimens (such as urine) would also be useful to verify self-
reported drug use. Further research is also needed to investigate
why there were only reductions in speciﬁc drugs in the current
study. Given the intersectoral innovation underlying this
research, that is, the linking of NGOs, community (peer outreach)
workers and researchers (Pinto, da Silva, & Soriano, 2012), it
would also be useful to better measure the dynamics going on
between the various players (e.g. NGO and researchers, NGO
and peer outreach workers, researchers and peer outreach
workers, and peer outreach workers and drug users).
Conclusion
Despite the above-mentioned limitations, the ﬁndings of the
current study and previous studies demonstrate that interventions
targeting NIDUs can reduce their substance use to a certain
degree, but may not affect other risk behaviours among this popu-
lation. In South Africa, limited attempts to bring HIV prevention,
treatment and care interventions into services for drug users have
been made, if these do exist they have been associated with a
number of challenges such as ﬁnances, geographic access barriers
and awareness of available services (Myers, 2010). This study
shows that it is feasible and acceptable to promote such compre-
hensive services with substance users, but that further nuances,
such as more intensive interventions, might be needed to have a
substantial impact on substance use and substance use-related
HIV risk behaviours.
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